Clinical Research Directory

Inclusion Criteria: * Ability to understand and give an informed consent, capacity to consent * Given informed consent * ≥ 18 years of age * Patients with newly diagnosed glioblastoma * Patients with IDH-mutant Astrocytoma, CNS WHO-Grade 4, newly diagnosed (by biopsy or incomplete tumor resection) * Patients eligible for radiochemotherapy with temozolomide and 60 Gy * Patients before radiochemotherapy phase or within the first 2 weeks * Prescription of TTFields according clinical routine (including but not exclusive to) * Access to a computer and internet * Absence of medical reasons precluding participation in a supportive intervention Exclusion Criteria: * Ability to understand and give an informed consent, capacity to consent * Given informed consent * ≥ 18 years of age * Being a family caregiver of a patient with newly diagnosed glioblastoma * Access to a computer and internet * Absence of medical reasons precluding participation in a supportive intervention